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THE ROLE OF ACETlLCHOLINE IN PEPTONE SHOCK
Introduction
It was the purpose of this tnesis to determine the relative importance
of the role of acetylcholine in the production of tne condition Known as
peptone shock. A series of acute experiments, using dogs as the experimental
animals, was performed to compare the efficacy of various methods of treat-
ment in alleviating this reaction.
De Yiiaele (5) in 1907 first noted the marked similarity between the
symptoms of peptone and anaphylactic shock. The essential difference be-
tween the two is that a solution of peptones or proteoses produces shock
when first injected, whereas an initial dose of antigen, followed by a second
injection after a suitable period of time has elapsed, is necessary to pro-
duce anaphylaxis. In the signs and symptoms produced, the two are quite
similar.
In 1910, soon after the discovery of histamine, Dale and Laidlaw ( 3 )
noted the close similarity between anaphy lactic and peptone shock and the
results produced by an injection of nistamine. Tney postulated that histamine
is the active substance producing the signs of anaphylaxis. This theory was
not substantiated until 1932, when Dragstedt (6) found, in blood from the
inferior vena cava and lymph from the tnoracic duct, a substance, appearing
during the early stages of anapnylactic shock in dogs, which behaved chemi-
cally and physiologically like histamine. It is now generally accepted that
histamine plays the major role in both peptone and anaphylactic shock.

With the introduction by Bovet and Stau'b (2) in 1937 of the first in
a series of compounds possessing marked anti-'nistaminic properties, the
importance of histamine in these conditions could be determined. N-Pyridyl-
N-benzyl-N
’ ,
N* -dimetnylethylenediamine hydrochloride, Pyribenzamine, intro-
duced in 1945 by Mayer, Huttrer and Scholz, (15)^ is a potent antihistaminic
drug, and has been widely used in this country. All the drugs which show a
marked antagonism to histamine are capable of diminishing the severity of
anaphylactic and peptone shock (12)
.
Several observations have been made which indicate that some other
factor(s) may be involved also. In 1936 Went and Lissak (20) observed tnat
the choline content of the isolated sensitized guinea pig neart decreased
following the addition of antigen, and that acetylation of the perfusing
fluid gave an acetylcholine-Iixe reaction with leech muscle. They also ob-
served that the isolated, sensitized rat heart slows wnen antigen is added
to the perfusion fluid.
Farber and his co-workers (7) found tnat in 10% of 27 isolated sensi-
tized guinea pig hearts there was an acetylcholine-like substance liberated
when antigen was added to perfusion fluid containing physostigmine . Normal
hearts did not show such activity
.
Wenner and Buhrmester (19) found that tne acetylcholine concentration
in the blood of rabbits in anaphylactic shock was 1:1,000,000 - 10,000,000,
while normal rabbits showed no measurable amounts of acetylcholine activity.
To explain tne origin of the increased acetylcholine present in shock,
irritation of cholinergic fibres has been postulated (ll) . But Kuchinski
(10) noted that the cholinesterase activity of the serum in cats and dogs
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is diminished, both in vitro and in vivo, when peptone is added. In vivo
there was a sharp drop in cholinesterase activity on administration of
peptone to about 50$ of normal, with a gradual rise to 10-15% of normal in
one hour. A decrease in cholinesterase activity has also been reported in
anaphylactic shock (ll)
.
If acetylcholine plays a role in the production of shock, pretreatment
with a substance blocking the effects of acetylcholine should lessen the
severity of such reactions.
Auer (1) in 1910 reported that atropine is of some value in anaphylac-
tic snock. Of 25 sensitized guinea pigs treated with atropine, 1-5 mgm. per
Kg., before reinfection of the sensitizing serum, 18 or 72% survived, while
of 24 similar pigs wnicn did not receive atropine 6 or 25$ survived.
Gross (8) has reported that, in dogs, 0.3 Gm./Kg. of Witte’ s peptone,
given intravenously, is the minimal lethal dose. Atropine, 0.2 mgm/Kg.,
prevented death in ail dogs receiving 0.5 Gm. of peptone. Atropine in this
dosage did not protect against the letnal effects of 0.6 Gm., however. Tne
number of dogs used was not stated.
On the other hand, in a report by Valiery-Radot, Maurice, and Haltzer,
(18) atropine, given in doses of 0.004-0.5 mgm/Kg., did not prevent anaphy-
lactic shocA in 7 rabbits. One rabbit receiving 0.5 mgm. and one receiving
1.0 mgm. per Kg. did not show shock. They concluded that atropine did not
prevent anaphylactic shocK.
Danieiopolou (4), however reports that atropine hinders, while eserine
aids, the production of anaphylactic shock. Dosages were not given.
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The relative importance of acetylcholine in these conditions has not
been determined. A series of experiments has been performed in an attempt
to compare the beneficial effects of an anti-acetylcholine drug and an anti-
histaminic compound in peptone shocx.
Methods
Mongrel dogs were anesthetized with sodium pentobarbital, given intra-
venously. The left carotid was exposed, cannulated, and connected with a U-
tube mercury manometer modified for use with the electrical recording system
described by Maison and Haterius (13) . Pulse rates were obtained by palpa-
tion. All drugs were administered via the femoral vein, which was exposed
for this purpose.
Atropine sulfate, 2.0 mgm./kg. and Pyribenzamine*, 10.0 mgm./Kg., either
alone or in combination were used as pre- peptone medication. These were
administered intravenously as a x.Q# solution. Ten to 15 minutes were allowed
to elapse after the administration of Pyribenzamine before peptone was given.
In the dogs receiving atropine, the right vagus was stimulated electrically
before and after the injection. In the dosage used, the cardiac vagus was
apparently blocked, as the same intensity of stimulus causing a marked fall
in blood pressure before atropine had no effect after the drug was given.
Five c.c. of a 20% solution (1.0 Gm.) of Witte's peptone intravenously was
then injected per kilogram body weight rapidly as possible, using a #22 nee-
dle. The time required for the injection was 1.5 to 3 minutes depending
upon the total volume used.
Tne Pyribenzamine used was supplied by Ciba Pharmaceutical Products, Inc
.*
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Results
Mortality: Three controls, receiving only peptone, died within 5 to 11
minutes after the beginning of the injection. Three vagotomized dogs died
also, one 5 minutes, one 20 minutes, and one 90 minutes after peptone. Of
three dogs pretreated with atropine, 3 with Pyribenzamine, ana 3 witn botn,
none died.
Pulse rates: During the peptone injection, the heart rate in all but
one of the animals slowed 4 to 52 beats per minute from the initial rate.
Within 2- 5 minutes after the injection, the rate increased, in all but 2,
to a level greater than that prior to peptone. Tnis is probably indicative
of a sympathetic discharge due to the hypotension present. Table 1 is a
tabulation of the changes in pulse rates occurring during and after peptone.
Pretreatment Expt. No. A B C
Atropine- SO^
2.0 mgm./Kg.
1
52
204
188
180
168
208
200
58 188 176 176
Pyribenzamine, 56 164 160 180
10 m6m./kg. 61 168 140 180
63 130 144 140
Pyribenzamine
,
4 160 144 150
10 mgm./Kg. 5 190 140 *.08
and 57 172 120 184
Atropine- S0^, 59 160 152 188
2.0 mgm./kg. 62 184 152 192
Table 1
Pulse rates (A) before, (B) during, and (C) 2-5 minutes after peptone.
Blood pressure: All tne dogs, regardless of the type of pretreatment,
showed an initial precipitous fall in blood pressure to about 30 millimeters
of mercury, beginning within 15 to 30 seconds after commencing the peptone
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injection. An example of this fall is seen in Fig. 1. Continuation of the
injection evoked a further fall of only 5 to 10 nun. in the treated animals,
while the controls showed a progressive decline to zero. In most of the
surviving animals the blood pressure began to rise within 4 to 10 minutes,
reached a peak in 9 to 16 minutes, declined a few millimeters and then began
a secondary more graduaj. rise within 20 to 30 minutes, reaching a plateau in
about one hour. (All time intervals given refer to the time elapsed from
the beginning of the peptone injection.) Three animals did not show the
initial peak, but exhibited a slow continuous rise until tne final plateau.
Otherwise they were similar to the remaining animals. A typical example of
the blood pressure changes for each of the three methods of treatment is
given in Fig. 2.
Since Pyribenzamine potentiates the response to epinephrine (16), the
blood pressure at 25 minutes post-peptone, at which time tne pressure was
at a plateau or just beginning its secondary rise, was used as an indication
of the degree of protection afforded by tne drugs, as this excluded tne
effects of the initial sympatnetic discnarge. Twenty-five minutes was
arbitrarily' chosen, as with further recovery, the differences between the
methods used became less marked. In Table II the blood pressure changes
are given.
None of the tnree methods of treatment prevented the initial fall in
blood pressure. Both the height of the initial peak and the pressure at 25
minutes were greater in tnose treated with Pyribenzamine alone than in those
receiving atropine alone. In the dosages used atropine protects dogs from
death due to peptone; Pyribenzamine afforded better protection than atropine.
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7A combination of the two afforded no better protection than Pyribenzamine
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Fig. 1
The effect upon the blood pressure of injection of peptone, 1.0 Gm/Kg. I.V.
Injection begun at A, completed at B. Time interval = 6 seconds. Pressure
at A = 140; pressure at B = 28.
Pretreatment Expt. No. A B C D
Atropine, SQ^, 1 138 30 60 45
2.0 mgm./Kg. 54 170 28 58 56
58 134 18 * 44
Pyribenzamine
,
56 126 52 122 112
10 mgm./Kg. 61 142 20 106 88
63 128 26 * 104
Pyribenzamine 4 80 28 112 106
10 rngm./Kg. 5 68 10 52 44
and 57 144 24 * 56
Atropine-S0^, 59 136 22 74 70
2.0 mgm./Kg. 62 136 24 74 80
* Showed no initial peak.
Table II. Tabulation of blood pressures (in mm. Hg.) (A) before peptone;
(b) lowest pressure reached when peptone given; (C) pressure at crest of
initial rise; (D) pressure at 25 minutes after peptone.
. 9flCX
... •
.
.
.
. cold floty
c
. s. U J . -Xi/fifc'.'- IC ; ,x
* .
3a ‘tl ‘
.1
.
.
. oc
r . j.
.
•
/ C ' .. ••• , ; ;
'
•» L • i
Fig. 2. Typical blood pressure changes occurring after administration
of peptone 1.0 Gm. per Kg. body weight. Pretreatment: #52 - Atropine sul-
phate 2.0 mgm/Kgj #61 - Pyribenzamine 10.0 Mgm./Kg.; #62 - Pyribenzamine
10.0 mgm/Kg. and atropine sulfate 2.0 mgno/Kg.
Discussion
The failure to prevent the initial fall in blood pressure is consistent
with the results of Yonkman, Hays, and Renninck (21) in anaphylactic shock.
They, however, reported that the heart is apparently not slowed during the
hypotensive pnase in anapnylaxis after pretreatment with Pyribenzamine, but
this does not agree with our results in peptone shock.
One difficulty to be overcome before accepting the hypothesis that
acetylcholine plays a role in the production of peptone shock is that, as
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yet, no drug is available which exhibits antagonism to acetylcholine witnout
possessing some antihistaminic action. Similarly all antihistaminic drugs
show a certain degree of anti-acetylcnoline activity. Various degrees of
specificity are possible however. Thus Pyribenzamine is 250 times as potent
as atropine against histamine as tested by the aerojol method of producing
histamine shocx in guinea pigs (9) (14). Atropine is much more effective
as an anticnolinergic drug than is ribenzamine . In our experience 10.0
mgm./Kg. of Pyribenzamine exerted only moderate vagal blockage, as compared
with 0.05 mgm./Kg. of atropine required for va^al blocking in the dog (17)
Fig. 3. Effect of vagal stimulation on blood pressure before A and
10 minutes after (B) pyribenzamine, 10 mgm./Kg. given I.V. The right vagus
was stimulated electrically at S. Time intervals = 10 seconds.
To protect 100$ of sensitized guinea pigs from lethal anaphylaxis,
0.3 mgm./Kg. of Pyribenzamine must be given (14) . The exact dosage required
to protect dogs has not been determined, but it seems to be somewhat greater.
Thus tne protective action of 2.0 mgm./Kg. of atropine in peptone shock can
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hardly be attributed to its antihistaminie properties. It seems much more
likely that the benefit derived is a result of its anticholinergic activity.
No explanation is offered for the observation tnat a combination of Pyri-
benzamine and atropine seems to less effective than Pyribenzamine alone.
The participation of acetylcholine in peptone or anaphylactic shock
is not accepted generally. Loew (12) states that no conclusive evidence has
been offered concerning its role in anaphylaxis. Danielopolou (4), on the
other hand, believes that acetylcholine is the most important factor, and
assigns a secondary role to histamine. More quantitative comparisons be-
tween the antihistaminics and anticholinergic drugs are necessary before the
question can be resolved, but the greater degree of protection afforded by
Pyribenzamine than by atropine, as evidenced in these experiments by the
blood pressure changes, is evidence that while histamine plays the major
role in the production of peptone shock, acetylcholine is also concerned.
Conclusions
1) One Cm./Kg. body weight of V»itte*s peptone administered intravenously
in a 20$ solution, is fatal in dogs anesthetized with sodium pentobarbital.
2) Atropine sulfate, 2.0 mg./Kg., prevents death from peptone in this
dosage
.
3) Pyribenzamine, 10.0 mgm./Kg., affords better protection than atropine
as determined by rapidity of recovery of blood pressure.
4) A combination of the two drugs affords no better protection than
Pyribenzamine alone.
5) These findings support the theory that t cetylcholine is concerned in
the production of peptone shock, although histamine plays a more important
role.
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THE ROLE OF ACETYLCHOLINE IN PEPTONE SHOCK
(Abstract)
Anaphylactic snock and the phenomenon produced by the injection of a
solution of peptones or proteoses exhibit quite similar signs and symptoms.
Both conditions are characterized by a release of histamine, which is
accepted to be the major factor in the production of these syndromes.
Various drugs have been introduced in the last ten years which possess
marked antihistamine activity. All such drugs are capable of diminishing
the severity of peptone and anaphylactic shock.
Other factors may also be involved, however. Aent and Lissak have
reported that tne choline content of the isolated, sensitized guinea pig
heart decreases following the addition of antigen to the perfusion fluid;
Farber et al found that 10% of such hearts .liberated an acety Ichoiine-like
substance when antigen was added, while 7i/enner and Buhrmester report that
tne acetylcholine concentration of the serum of rabbits in anaphylactic
shock is nigher than that of normals.
These observations may be explained by the observation by Kucninsxi
that the cholinesterase activity of the serum of animals is decreased to
about 50% of normal when peptone is given. The serum cholinesterase is
also diminished in anaphylactic shock.
If the release of acetylcholine is concerned in the production of the
state of snock, atropine should alleviate the condition. Auer has reported
that such is the case in anaphylaxis in guinea pigs, while Gross has re-
ported that atropine is of value in peptone shock. Others have failed to
confirm these findings, however.
BOSTON UNIVERSITY
COLLEGE OF LIBERAL ARTS
LIBRARY
JL Iwi' 'U f&JA
- c.
(. j..a . ,
; a .'-.ifi-L I ' -
i.
'
j. <. ;i '
<
• '
-
I • ;• 1 : >.
-
|
. iJ J .. 31 ; .. w. . «Ji i .
•V . iu /'
t •• V i JJ-uC • Mj* t '<
•l
To compare the efficacy of atropine and Pyribenzamine (N'-pyridyl-
N’-benzyl-N-dimetnylenediamine’HCj.)
,
one of the more potent antihist&minic
compounus, and thus compare the relative importance of acetylcholine and
histamine in peptone shock, a series of experiments was performed, using
dogs anesthetized with soaium pentobarbital. Carotid blood pressure was
recorded, and pulse rates were followed. Atropine sulfate, 2.0 mgm./Kg.,
and Pyribenzamine, 10.0 mgm./Kg., were given as pie- peptone treatment,
either alone or in combination. A 20% solution of Witte’s peptone, 5.0 c.c./
Kg., was then injected via the femoral vein.
Three controls, receiving only peptone, and three vagotomized dogs died.
Of three dogs treated with atropine, three with Pyribenzamine, and five
receiving both, none died.
During the peptone injection the heart rate slowed in all dogs except
one. In 2 to 5 minutes after the injection most of the surviving animals
showed an increase in heart rate to a level greater than that prior to the
peptone injection.
With 30 seconds after the beginning of the injection, all the dogs
show-ed a precipitous fall in blood pressure to about 30 millimeters of mer-
cury. In those animals which survived, the pressure began to rise in 4 to
10 minutes after the injection, reacned a peak in 9 to 16 minutes, declined
slightly and then began a slower secondary" rise reacning a plateau in about
one hour. Those receiving Pyribenzamine showed a greater initial rise and
a higher pressure at 25 minutes after peptone than those receiving atropine.
The dogs receiving both drugs varied considerably in their response,
but none showed a greater degree of recovery than those receiving Pyriben-
zamine alone.
i< (i.C
,
,
. , _
. .
:
, V "i - 'o - t (
* . « -
.
. . .1
.
.jw £
t ....
- ...
, . .
..
.
.1 Ci.i.iO : 'U J- c ' • -i-' 1 • - M .1 •• • *» • :*
. tic j Biidi
.
H, v
;. •; •. a .'. .L . Z C;k iU . £ ' J
i\ ; -
j.
Our failure to prevent the initial fall in blood pressure is consistent
with the reports of others.
The antihistaminic potency of atropine is l/250 that of Pyribenzamine.
More than 0.3 mgm./Kg. of Pyribenzamine is necessary to protect dogs from
death in anaphylaxis. Thus the dosage of atropine used, 2.0 mgm./Kg., can
hardly have exerted its beneficial effect in peptone shock through its
antihistaminic effects, but did so probably via its anti-acetylcholine
activity.
Conclusions
1. Viitte's peptone, 1.0 Gm./Kg. body weight, given intravenously as
a 20% solution, is fatal in dogs anesthetized with sodium pentobarbital.
2. Atropine sulfate, 2.0 mgm./Kg., prevents death from this dosage of
peptone.
3. Pyribenzamine, 10.0 mgm./Kg., affords better protection than atropine,
as determined ty rapidity of recovery of blood pressure.
4. A combination of the two drugs affords no better protection than
Pyribenzamine alone.
5. These findings support the theory that acetylcholine is concerned in
the production of peptone shock, although histamine plays a more important
role
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